Lysine and Entresto drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lysine (lysine) and Entresto (sacubitril; valsartan). Common drug interactions include infection among females and confusional state among males.
The phase IV clinical study analyzes what interactions people have when they take Lysine and Entresto. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.
What is Lysine?
Lysine has active ingredients of lysine. It is often used in herpes labialis (oral herpes simplex). eHealthMe is studying from 16,524 Lysine users. Check the latest studies of Lysine.
What is Entresto?
Entresto has active ingredients of sacubitril; valsartan. eHealthMe is studying from 126,628 Entresto users. Check the latest studies of Entresto.
21 people who take Lysine and Entresto together, and have interactions are studied.
What are the common drug interactions of Lysine and Entresto, by gender? *:
female:
- Infection
- Device expulsion
- Eye pain
- Peripheral swelling
- Vaginal odour
- Vulvovaginal discomfort
male:
- Confusional state
- Dyskinesia (abnormality or impairment of voluntary movement)
- Cardiac failure congestive
- Chest pain
- Chills (felling of cold)
- Coronary arterial stent insertion
- Cough
- Dizziness
- Dry skin
- Fatigue (feeling of tiredness)
What are the common drug interactions of Lysine and Entresto, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Confusional state
- Dyskinesia (abnormality or impairment of voluntary movement)
- Immune system disorder
- Sinusitis (inflammation of sinus)
60+:
- Myalgia (muscle pain)
- Confusional state
- Chest pain
- Chills (felling of cold)
- Coronary arterial stent insertion
- Cough
- Dizziness
- Dry skin
- Fatigue (feeling of tiredness)
- Headache (pain in head)
What are the existing conditions these people have? *
- Neuropathy Peripheral (surface nerve damage): 4 people, 19.05%
- Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 4 people, 19.05%
- Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 2 people, 9.52%
- Cystic Fibrosis Lung (fibrosis with cyst in the lung): 2 people, 9.52%
- Cystic Fibrosis (disease of the secretary glands): 2 people, 9.52%
* Approximation only. Some reports may have incomplete information.
Do you take Lysine and Entresto?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lysine and Entresto:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lysine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Entresto:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lysine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Entresto and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on lysine and sacubitril; valsartan (the active ingredients of Lysine and Entresto, respectively), and Lysine and Entresto (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Oxycodone cause Deafness Neurosensory? - a second ago
- Drug interactions of Evening Primrose Oil and Q10 - 5 seconds ago
- Could Tecentriq cause Joint Pain? - 10 seconds ago
- Drug interactions of Hydrocortisone and Fintepla - 10 seconds ago
- Pneumocystis Jiroveci Pneumonia and Jaundice - Yellow Skin - 19 seconds ago
- Could Tukysa cause Brain Oedema? - 28 seconds ago
- Could Tasmar cause Acute Circulatory Failure? - 40 seconds ago
- Could Leukeran cause Itching? - 43 seconds ago
- Could Ascorbate cause Dyspepsia Aggravated? - 50 seconds ago
- Drug interactions of Fentanyl and Tasigna - 52 seconds ago